Clorox price target lowered to $164 from $170 at UBS

UBS lowered the firm’s price target on Clorox to $164 from $170 and keeps a Neutral rating on the shares. While Clorox announced the divestiture of its operations in Argentina, Uruguay, and Paraguay to Apex Capital and did not reiterate its underlying guidance, UBS does not believe this language was intended to be a sign that the underlying business has softened, the analyst tells investors in a research note.